Sermorelin is a synthetic version of naturally occurring growth hormone-releasing hormone (GHRH)
Unlike GLP-1 agonists, which primarily act by delaying gastric emptying and enhancing insulin secretion, BRP operates via the following mechanisms: Hypothalamic activation : BRP triggers the expression of the FOS gene, a key marker of neuronal activation associated with appetite suppression, in the hypothalamus
Typical cycles range from 4-6 weeks under medical supervision, followed by an off period to maintain receptor sensitivity
These medications, originally approved by the FDA for the treatment of Type 2 diabetes, have since been authorized for weight loss therapy and are now recommended by the American Diabetes Association as potential first-line options for both indications
Skin tightness: Some users have reported feeling tight on their skin during the initial use, especially in dry environments